These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 1983967)
1. Characterization of autoantibodies to the CD4 molecule in human immunodeficiency virus infection. Sekigawa I; Groopmen JE; Allan JD; Ikeuchi K; Biberfield G; Takatsuki K; Byrn RA Clin Immunol Immunopathol; 1991 Jan; 58(1):145-53. PubMed ID: 1983967 [TBL] [Abstract][Full Text] [Related]
2. Detection of T cell CD4 epitopes in HIV-infected individuals. Kunkl A; Valle MT; Fenoglio D; Dodi F; Morandi N; Rizzo F; Manca F Eur J Histochem; 1994; 38 Suppl 1():41-6. PubMed ID: 8547709 [TBL] [Abstract][Full Text] [Related]
3. Humoral Antibody Responses to HIV Viral Proteins and to CD4 Among HIV Controllers, Rapid and Typical Progressors in an HIV-Positive Patient Cohort. Fink E; Fuller K; Agan B; Berger EA; Saphire A; Quinnan GV; Elder JH AIDS Res Hum Retroviruses; 2016 Dec; 32(12):1187-1197. PubMed ID: 27771962 [TBL] [Abstract][Full Text] [Related]
4. Detection of anti-CD4 autoantibodies in the sera of HIV-infected patients using recombinant soluble CD4 molecules. Chams V; Jouault T; Fenouillet E; Gluckman JC; Klatzmann D AIDS; 1988 Oct; 2(5):353-61. PubMed ID: 3146263 [TBL] [Abstract][Full Text] [Related]
5. Autoantibodies against CD4 cells are associated with CD4 helper defects in human immunodeficiency virus-infected patients. Weimer R; Daniel V; Zimmermann R; Schimpf K; Opelz G Blood; 1991 Jan; 77(1):133-40. PubMed ID: 1824617 [TBL] [Abstract][Full Text] [Related]
6. Anti-CD4 autoantibodies and screening for anti-idiotypic antibodies to anti-CD4 monoclonal antibodies in HIV-seropositive people. Wilks D; Walker LC; Habeshaw JA; Youle M; Gazzard B; Dalgleish AG AIDS; 1990 Feb; 4(2):113-8. PubMed ID: 2328093 [TBL] [Abstract][Full Text] [Related]
7. Autoantibodies in HIV-infected hemophilia patients against different epitopes on CD4+ lymphocytes and recombinant CD4. Daniel V; Weimer R; Zettlmeissl G; Langner K; Zimmermann R; Opelz G Vox Sang; 1992; 62(1):39-44. PubMed ID: 1374580 [TBL] [Abstract][Full Text] [Related]
8. CD4 peptide-protein conjugates, but not recombinant human CD4, bind to recombinant gp120 from the human immunodeficiency virus in the presence of serum from AIDS patients. Ghetie V; Slaughter C; Wheeler HT; Uhr JW; Vitetta ES Proc Natl Acad Sci U S A; 1991 Jul; 88(13):5690-3. PubMed ID: 2062847 [TBL] [Abstract][Full Text] [Related]
9. Internal-image anti-idiotype HIV-1gp120 antibody in human immunodeficiency virus 1 (HIV-1)-seropositive individuals with thrombocytopenia. Karpatkin S; Nardi MA; Kouri YH Proc Natl Acad Sci U S A; 1992 Feb; 89(4):1487-91. PubMed ID: 1741404 [TBL] [Abstract][Full Text] [Related]
10. Biological properties of anti-CD4 autoantibodies purified from HIV-infected patients. Chams V; Idziorek T; Klatzmann D AIDS; 1991 May; 5(5):565-9. PubMed ID: 1677809 [TBL] [Abstract][Full Text] [Related]
11. Interference of recombinant soluble CD4 immunoglobulin G in flow cytometric measurement of CD4+ lymphocytes. Kidd PG; Austin GD; Collier AC; Arditti DE; Coombs RW; Corey L Am J Clin Pathol; 1992 Feb; 97(2):166-9. PubMed ID: 1546684 [TBL] [Abstract][Full Text] [Related]
12. Enhancement of soluble CD4-mediated HIV neutralization and gp 120 binding by CD4 autoantibodies and monoclonal antibodies. Moore JP; Sattentau QJ; Clapham PR AIDS Res Hum Retroviruses; 1990 Nov; 6(11):1273-9. PubMed ID: 2078408 [TBL] [Abstract][Full Text] [Related]
13. CD4-imitating human antibodies in HIV infection and anti-idiotypic vaccination. Deckert PM; Ballmaier M; Lang S; Deicher H; Schedel I J Immunol; 1996 Jan; 156(2):826-33. PubMed ID: 8543839 [TBL] [Abstract][Full Text] [Related]
14. CD4-derived synthetic peptide blocks the binding of HIV-1 GP120 to CD4-bearing cells and prevents HIV-1 infection. Shapira-Nahor O; Golding H; Vujcic LK; Resto-Ruiz S; Fields RL; Robey FA Cell Immunol; 1990 Jun; 128(1):101-17. PubMed ID: 1971526 [TBL] [Abstract][Full Text] [Related]
15. Anti-CD95 (APO-1/Fas) autoantibodies and T cell depletion in human immunodeficiency virus type 1 (HIV-1)-infected children. Stricker K; Knipping E; Böhler T; Benner A; Krammer PH; Debatin KM Cell Death Differ; 1998 Mar; 5(3):222-30. PubMed ID: 10200468 [TBL] [Abstract][Full Text] [Related]
16. Isotypes and IgG subclasses of anti-Fab antibodies in human immunodeficiency virus-infected hemophilia patients. Süsal C; Oberg HH; Daniel V; Dörr C; Terness P; Huth-Kühne A; Zimmermann R; Opelz G Vox Sang; 1994; 66(1):37-45. PubMed ID: 7908473 [TBL] [Abstract][Full Text] [Related]
17. Differential isotype expression and binding properties of T cell-reactive antibodies in human immunodeficiency virus (HIV) infection. Silvestris F; Azzolini C; Dammacco F J Clin Immunol; 1992 Mar; 12(2):107-15. PubMed ID: 1373149 [TBL] [Abstract][Full Text] [Related]
18. HIV-1 envelope glycoprotein gp120 down-regulates CD4 expression in primary human macrophages through induction of endogenous tumour necrosis factor-alpha. Karsten V; Gordon S; Kirn A; Herbein G Immunology; 1996 May; 88(1):55-60. PubMed ID: 8707350 [TBL] [Abstract][Full Text] [Related]
19. Resistance of primary isolates of human immunodeficiency virus type 1 to soluble CD4 is independent of CD4-rgp120 binding affinity. Ashkenazi A; Smith DH; Marsters SA; Riddle L; Gregory TJ; Ho DD; Capon DJ Proc Natl Acad Sci U S A; 1991 Aug; 88(16):7056-60. PubMed ID: 1871120 [TBL] [Abstract][Full Text] [Related]
20. Characterization of new monoclonal antibodies that discriminate between soluble and membrane CD4 and compete with human anti-CD4 autoimmune sera. Denisova G; Lideman L; Spectorman E; Abulafia-Lapid R; Burke M; Yust I; Gershoni JM Mol Immunol; 2003 Sep; 40(5):231-9. PubMed ID: 12943795 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]